Drug or alcohol use, or both following treatment completion ‐ Individual‐based intervention · Individuals with post‐traumatic stress disorder and comorbid substance use disorder
1 finding from 1 review
Drug or alcohol use, or both following treatment completion ‐ Individual‐based intervention · Individuals with post‐traumatic stress disorder and comorbid substance use disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality ‐ sensitivity analysis · patients with Pneumocystis pneumonia (PCP) in non‐HIV immunocompromised patients
TMP/SMX showed no clear difference in all cause mortality ‐ TMP/SMX versus placebo or no treatment compared with placebo, no treatment or non‐PCP drug (low certainty).
1 finding from 1 review
Adverse events: severe adverse events requiring treatment discontinuation ‐ TMP/SMX versus placebo or no treatment Clinical and laboratory criteria and treatment discontinuations · patients with Pneumocystis pneumonia (PCP) in non‐HIV immunocompromised patients
TMP/SMX showed no clear difference in adverse events: severe adverse events requiring treatment… compared with placebo, no treatment or non‐PCP drug (moderate certainty).
1 finding from 1 review
Barnes Akathisia Scale LOCF at week 12 A physician‐assessed rating scale to assess the severity of drug‐induced akathisia Scale from 0 to 14 · patients with an acute manic or mixed episode
1 finding from 1 review
no estimate extracted
646 participants
Low
Simpson Angus Scale LOCF at week 12 A physician‐administered rating scale to measure drug‐induced Parkinsonism Scale from 0 to 40. · patients with an acute manic or mixed episode
1 finding from 1 review
no estimate extracted
646 participants
Low
Treatment withdrawal · lung transplant recipients
Tacrolimus may leads to lower treatment withdrawal the number of patients stopping the assigned… compared with cyclosporin (low certainty).
1 finding from 1 review
Ongoing pregnancy · assisted reproductive technology
It is very uncertain whether nonsteroidal anti‐inflammatory drugs changes ongoing pregnancy compared with placebo/ no treatment (very low certainty).
1 finding from 1 review
Miscarriage · assisted reproductive technology
It is very uncertain whether nonsteroidal anti‐inflammatory drugs changes miscarriage compared with placebo/ no treatment (very low certainty).
1 finding from 1 review
Clinical pregnancy · assisted reproductive technology
Nonsteroidal anti‐inflammatory drugs showed no clear difference in clinical pregnancy compared with placebo/ no treatment (low certainty).
1 finding from 1 review
Ectopic pregnancy · assisted reproductive technology
It is very uncertain whether nonsteroidal anti‐inflammatory drugs changes ectopic Pregnancy compared with placebo/ no treatment (very low certainty).
1 finding from 1 review
Multiple pregnancy · assisted reproductive technology
It is very uncertain whether nonsteroidal anti‐inflammatory drugs changes multiple pregnancy compared with placebo/ no treatment (very low certainty).
1 finding from 1 review
Side effects · assisted reproductive technology
It is very uncertain whether nonsteroidal anti‐inflammatory drugs changes side effects compared with placebo/ no treatment (very low certainty).
1 finding from 1 review
Recurrent stroke of any type · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) probably leads to lower recurrent stroke of any type compared with placebo or no treatment (moderate certainty).
2 findings from 1 review
Stroke, myocardial infarction, or vascular death · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) showed no clear difference in major vascular event (composite of non‐fatal stroke, non‐fatal… compared with placebo or no treatment (high certainty).
1 finding from 1 review
Myocardial infarction · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) showed no clear difference in myocardial infarction compared with placebo or no treatment (high certainty).
1 finding from 1 review
Deaths due to vascular events · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) leads to lower vascular death compared with placebo or no treatment (high certainty).
1 finding from 1 review
Death by any cause · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) showed no clear difference in death by any cause compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Dementia · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) showed no clear difference in dementia compared with placebo or no treatment (high certainty).
1 finding from 1 review
Systemic fungal infection · Patients with cancer receiving chemotherapy and/or radiotherapy
Antifungal drugs absorbed from GI tract showed no clear difference in systemic fungal infection compared with antifungal drugs not absorbed from GI tract; GRADE not reported.
1 finding from 1 review